Qube Research & Technologies Ltd - CUREVAC N V ownership

CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 84 filers reported holding CUREVAC N V in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of CUREVAC N V
ValueSharesWeighting
Q4 2022$81,658
-60.2%
13,542
-48.0%
0.00%
-100.0%
Q3 2022$205,000
-79.7%
26,048
-64.9%
0.00%
-85.7%
Q2 2022$1,010,000
+254.4%
74,211
+2008.9%
0.01%
+75.0%
Q4 2020$285,0003,5190.00%
Other shareholders
CUREVAC N V shareholders Q1 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 3,134,780$107,600,00032.65%
Affinity Asset Advisors, LLC 50,000$1,716,0000.62%
Renaissance Capital LLC 21,659$743,0000.19%
Eversept Partners, LP 85,017$2,916,9330.19%
TWINBEECH CAPITAL LP 67,504$2,316,0000.13%
Alpine Global Management, LLC 23,033$790,0000.12%
Paradigm Financial Advisors, LLC 13,535$464,0000.10%
Caption Management, LLC 200,000$6,860,0000.08%
Baillie Gifford 3,923,340$134,610,0000.07%
Donoghue Forlines LLC 11,570$397,0000.07%
View complete list of CUREVAC N V shareholders